EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

TARGETING THE FEMALE ENDOCANNABINOID SYSTEM (FECS) ACROSS PREGNANCY AND POSTPARTUM: NEUROENDOCRINE, IMMUNE, METABOLIC, AND CULTURAL PATHWAYS IN MATERNAL HEALTH: A CRITICAL NARRATIVE REVIEW

Clare Petal Persad

GSC Biological and Pharmaceutical Sciences · 01.11.2026 · 37 (2) · 134

DOI: 10.30574/gscbps.2026.37.2.0384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GSC Biological and Pharmaceutical Sciences, online erschienen am 01.11.2026. Verfasst von Clare Petal Persad. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endocannabinoid system (ECS) is an endogenous lipid-signaling network involved in reproductive, neuroendocrine, immune, metabolic, stress-related, and lactational physiology. Pregnancy and the postpartum transition provide an important period for examining this system, as maternal physiology changes throughout implantation, placentation, parturition, lactation, and postpartum recovery. This critical narrative review examines the female endocannabinoid system (FECS) as a reproductive and maternal-health organizing framework rather than as a separate molecular system. Human evidence indicates that endocannabinoid components are present at the maternal–fetal interface, anandamide concentrations vary across gestation and rise around labor, and endocannabinoid-related biomarkers change across the pregnancy-to-postpartum transition. Human milk contains a complex endocannabinoid and related lipid metabolome, with measurable variation by lactation stage, diurnal timing, and maternal metabolic characteristics. However, biomarker concentrations cannot be assumed to represent total ECS function, and current evidence does not support a single endocannabinoid-deficiency model for postpartum psychological disorders. The review integrates reproductive endocrine, immune, metabolic, stress, sleep, lactational, psychological, and cultural dimensions and proposes a pregnancy-to-postpartum FECS research platform based on longitudinal, multimatrix phenotyping. Endogenous endocannabinoid physiology is distinguished from exogenous exposure to cannabis, THC, and CBD. Accordingly, “targeting the FECS” refers primarily to physiological characterization, biomarker investigation, mechanistic research, and future translational development rather than recommending cannabinoid administration during pregnancy or lactation.

Zitieren

APA

Persad, C. P. (2026). TARGETING THE FEMALE ENDOCANNABINOID SYSTEM (FECS) ACROSS PREGNANCY AND POSTPARTUM: NEUROENDOCRINE, IMMUNE, METABOLIC, AND CULTURAL PATHWAYS IN MATERNAL HEALTH: A CRITICAL NARRATIVE REVIEW. GSC Biological and Pharmaceutical Sciences, 37(2), 134. https://doi.org/10.30574/gscbps.2026.37.2.0384

Vancouver

Persad CP. TARGETING THE FEMALE ENDOCANNABINOID SYSTEM (FECS) ACROSS PREGNANCY AND POSTPARTUM: NEUROENDOCRINE, IMMUNE, METABOLIC, AND CULTURAL PATHWAYS IN MATERNAL HEALTH: A CRITICAL NARRATIVE REVIEW. GSC Biological and Pharmaceutical Sciences. 2026;37(2):134. doi:10.30574/gscbps.2026.37.2.0384

BibTeX
@article{Persad2026,
  author = {Persad, Clare Petal},
  title = {TARGETING THE FEMALE ENDOCANNABINOID SYSTEM (FECS) ACROSS PREGNANCY AND POSTPARTUM: NEUROENDOCRINE, IMMUNE, METABOLIC, AND CULTURAL PATHWAYS IN MATERNAL HEALTH: A CRITICAL NARRATIVE REVIEW},
  journal = {GSC Biological and Pharmaceutical Sciences},
  year = {2026},
  volume = {37},
  number = {2},
  pages = {134},
  doi = {10.30574/gscbps.2026.37.2.0384}
}
Kostenlos starten →